Clenbuterol: Clinical Trials

9 trials of Clenbuterol, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 recruiting, 2 unknown, 1 terminated. 5 Phase 2, 3 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Recruiting 1, Withdrawn 1
Phase 13Completed 1, Recruiting 1, Terminated 1
Not applicable2Unknown 2

Follow Clenbuterol: new trials by email Literature Review of Clenbuterol trials Research Report on Clenbuterol

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clenbuterol to Target DUX4 in FSHD
Clenbuterol - Muscular Dystrophy, Facioscapulohumeral
Phase 1RecruitingJeffrey Statland302025-06-252026-02-25
A Placebo-controlled Study of Clenbuterol in Spinal and Bulbar Muscular Atrophy
Clenbuterol, Placebo - Spinal and Bulbar Muscular Atrophy
Phase 2RecruitingGianni Soraru902024-04-132024-04-15
Muscle Memory After Treatment With Anabolic Substance Clenbuterol and Resistance Training in Humans
Clenbuterol, Placebo - Skeletal Muscle Physiology
Not applicableUnknownMorten Hostrup, PhD602023-02-012023-01-20
Phase II Clinical Trial of Clenbuterol in Adult Patients With Pompe Disease
Clenbuterol, Placebos - Pompe Disease (Late-onset)
Phase 2WithdrawnDuke University2023-01-012022-08-17
A Study of Clenbuterol (CST-103) Co-administered With Nadolol (CST-107) in Subjects With Neurodegenerative Disorders
clenbuterol (CST-103), nadolol (CST-107), matching placebo - Mild Cognitive Impairment, Lewy Body Dementia, Parkinson's Disease Rapid Eye Movement Sleep Behavior Disorder, Parkinson's Disease Dementia
Phase 2CompletedCuraSen Therapeutics, Inc.412021-06-282024-12-02
Clenbuterol on Motor Function in Individuals With Amyotrophic Lateral Sclerosis
Clenbuterol - Amyotrophic Lateral Sclerosis
Phase 2CompletedDwight Koeberl, M.D., Ph.D.252020-02-102022-09-06
cAMP Signaling and Muscle Adaptations
No training, Endurance training, Resistance Training - Muscle Hypertrophy in Healthy Young Men
Not applicableUnknownUniversity of Copenhagen722015-07-012017-10-26
Safety and Efficacy of Clenbuterol in Individuals With Late-onset Pompe Disease and Receiving Enzyme Replacement Therapy
Clenbuterol, Placebo - Pompe Disease
Phase 1 / Phase 2CompletedDwight Koeberl, M.D., Ph.D.172013-09-012019-07-02
Harefield Recovery Protocol Study for Patients With Refractory Chronic Heart Failure
clenbuterol - Heart Failure, Dilated Cardiomyopathy
Phase 1TerminatedFrancis D. Pagani182007-07-012017-12-15

Conditions studied

Glycogen Storage Disease Type II (2)  ·  Amyotrophic Lateral Sclerosis (1)  ·  Bulbo-Spinal Atrophy, X-Linked (1)  ·  Cardiomyopathy, Dilated (1)  ·  Cognitive Dysfunction (1)  ·  Heart Failure (1)  ·  Lewy Body Disease (1)  ·  Muscular Dystrophy, Facioscapulohumeral (1)

Sponsors

Dwight Koeberl, M.D., Ph.D. (2)  ·  CuraSen Therapeutics, Inc. (1)  ·  Duke University (1)  ·  Francis D. Pagani (1)  ·  Gianni Soraru (1)  ·  Jeffrey Statland (1)  ·  Morten Hostrup, PhD (1)  ·  University of Copenhagen (1)

Countries

United States (5)  ·  Denmark (2)  ·  Australia (1)  ·  Italy (1)  ·  New Zealand (1)  ·  United Kingdom (1)

Top investigators

Dwight D Koeberl, MD, PhD (1)  ·  Dwight Koeberl, MD, PhD (1)  ·  Francis D. Pagani, MD, PhD (1)  ·  Keith D. Aaronson, MD, MS (1)  ·  Leslie W. Miller, MD (1)

Results publications

PMID 30025991, PMID 42730843

NIH funding

P50AR065139 (1)